Form 4: Oracle Grants Executive Chairman Ellison Stock Options
Insider Transaction Report
Oracle's Executive Chairman and CTO, Lawrence J. Ellison, was granted 571,286 stock options with an exercise price of $280.07, vesting annually over four years.
Summary
- Lawrence Joseph Ellison, Executive Chairman and Chief Technology Officer of Oracle Corp, was granted 571,286 stock options.
- The transaction date for this grant was October 23, 2025.
- The exercise price for these stock options is $280.07 per share.
- Each option represents the right to acquire one share of Oracle Common Stock.
- The options will vest at a rate of 25% annually on each anniversary of the grant date.
- The expiration date for these stock options is October 23, 2035.
- Following this transaction, Lawrence J. Ellison directly beneficially owns 571,286 derivative securities.
Sentiment
Score: 7
Explanation: The grant of stock options to a key executive is generally a positive event for the executive and a standard, often positive, practice for the company as it aligns interests and incentivizes performance. It is not a direct financial gain for the company but a strategic compensation move.
Positives
- The grant of stock options aligns the interests of Executive Chairman and CTO Lawrence J. Ellison with those of shareholders, incentivizing long-term performance.
- This equity award serves as a retention mechanism for a key executive, ensuring continued leadership and strategic direction.
Future Outlook
The grant of stock options to a key executive like Lawrence J. Ellison indicates a long-term incentive structure designed to align management's financial interests with the company's future performance and shareholder value creation.
Industry Context
Granting stock options to executive leadership is a common practice in the technology industry, used to attract, retain, and motivate top talent by providing a direct stake in the company's long-term success and stock performance.
Stakeholder Impact
- Shareholders: Potential for future dilution upon exercise of options, but also benefit from incentivized management focused on long-term stock appreciation.
- Lawrence J. Ellison: Significant potential for personal wealth creation tied directly to Oracle's stock performance.
Next Steps
- Continued vesting of the granted stock options annually on each anniversary of the grant date.
Key Dates
| Date | Description |
|---|---|
| 10/23/2025 | Date of earliest transaction (grant date of stock options) |
| 10/23/2026 | First annual vesting date (25% of options vest) |
| 10/23/2027 | Second annual vesting date (25% of options vest) |
| 10/23/2028 | Third annual vesting date (25% of options vest) |
| 10/23/2029 | Fourth annual vesting date (final 25% of options vest) |
| 10/23/2035 | Expiration date of the stock options |
| 10/27/2025 | Signature date of the reporting person's attorney-in-fact |
Recommendation
holdThis filing reports a routine executive stock option grant, which is a standard component of compensation and incentive. It does not present new information that would significantly alter the fundamental investment outlook for Oracle, hence a 'hold' recommendation is appropriate for existing investors.
Keywords
Oracle, ORCL, Lawrence Ellison, Stock Option, Executive Compensation, Form 4, Insider Transaction, Equity Grant, CTO, Executive Chairman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.